08:26 AM EDT, 07/30/2024 (MT Newswires) -- Repligen ( RGEN ) reported Q2 adjusted earnings Tuesday of $0.33 per diluted share, down from $0.53 a year earlier.

Analysts polled by Capital IQ expected $0.33.

Revenue for the quarter ended June 30 was $154.1 million, down from $159.2 million a year earlier.

Analysts polled by Capital IQ expected $154.1 million.

The company said it continues to expect 2024 adjusted EPS of $1.42 to $1.49. Analysts surveyed by Capital IQ expect $1.45.

The revenue outlook for 2024 was narrowed to $620 million to $635 million, from $620 million to $650 million previously. Analysts surveyed by Capital IQ expect $636.3 million.

Repligen ( RGEN ) shares were 1.5% lower in premarket trading.

Price: 136.00, Change: -2.00, Percent Change: -1.45